Published company evidence
Read the context behind each recommendation, including the study it came from and the limits of what the evidence can show.
272 published fit reviews
Transamerica is a mixed fit for life insurance after breast cancer. Trendsetter LB term and Final Expense Solutions Portfolio offer no-exam pathways, but no published breast-cancer underwriting grid exists, so stage, treatment timing, and recurrence outcomes stay case-by-case.
Prudential is a good, case-dependent fit for life insurance after breast cancer, not a guaranteed one. It offers documented breast-cancer-specific underwriting guidance, but approval, rating class, and price remain unverifiable until underwriting.
Lincoln Financial is a good but not automatically superior fit for a U.S. breast-cancer survivor seeking individually underwritten life insurance. Five of the seven platforms in this study named Lincoln Financial during the ranking stage, and it finished with an average listed rank of 2.2 and a best rank of 1.
Banner Life is a mixed-to-good fit for Life Insurance After Breast Cancer, not a clear best choice. Six of seven platforms named Banner Life during the ranking stage, and it placed third overall with an average listed rank of 3.17 and a best rank of 2.
Pacific Life is a mixed fit for life insurance after breast cancer. Its PL Promise Term with the PAL+ program offers no-exam coverage up to $3 million and conversion without new underwriting, but no breast-cancer-specific underwriting table is published.
Mutual of Omaha is a mixed fit for life insurance after breast cancer. Its guaranteed-issue whole life policy accepts ages 45-85 with no exam or health questions, but coverage is capped at final-expense amounts and a two-year limited-benefit period may apply.
Ethos is a mixed fit for U.S. cancer survivors seeking life insurance. Two of seven platforms named Ethos during ranking discovery, and six of seven returned a usable fit assessment; five rated it "mixed" and one rated it "good." The strongest reason to consider Ethos is its digital application with accelerated or…
John Hancock is a mixed fit for cancer survivors seeking life insurance. It offers term and universal life coverage with a cancer-specific underwriting framework and the optional Vitality wellness program, but no complete published cancer-survivor underwriting schedule. Approval and pricing remain case-specific.
Transamerica is a mixed fit for cancer survivors seeking life insurance. Its Final Expense Solutions Portfolio offers simplified-issue whole life with no exam and up to $50,000, but recent, metastatic, or recurrent cancers are declined.
Symetra is a mixed-to-strong fit for life insurance after cancer. It offers a documented early-stage cancer underwriting specialty and a Cancer Care Compass rider on select IUL policies, but publishes no cancer-specific underwriting grid and no survivor pricing.
Protective is a mixed, case-dependent fit for life insurance for cancer survivors. It markets medically underwritten term and universal life and is called a high-risk underwriting leader, but no public source documents a cancer-survivor acceptance program, waiting periods, or survivor pricing.
Lincoln Financial is a mixed fit for Life Insurance for Cancer Survivors. Five of seven platforms named it during the ranking stage, and its strongest asset is traditional medical underwriting through Lincoln LifeElements Level Term, which lets survivors document remission status and can produce standard or…
